02361 SINOHEALTH TECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 7.21X | Oper Margin | 25.4% |
|---|---|---|---|
| LT Debt/Equity | 0.6% | Net Margin | 22.3% |
| Total Debt/Equity | 1.1% | Return on Equity | 12.4% |
| Price/Book | 2.74X | Return on Assets | 10.8% |
| (HKD 5.100) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 104.00 | 117.68 | 112.46 | 62.52 | 96.40 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -11.6 | +4.6 | +79.9 | -35.2 | +19.6 |
| Earnings Per Share (HKD) | 0.23 | 0.287 | 0.264 | 0.152 | 0.258 |
| Earnings Per Share Growth (%) | -19.8 | +8.7 | +73.4 | -41.1 | +100.0 |
| Dividend Per Share (HKD) | 0.071 | 0.216 | 0.073 | 0.040 | No dividend |
| P/E* (X) | 22.15 | 17.78 | 19.33 | 33.51 | 19.74 |
| Yield (%) | 1.40 | 4.23 | 1.42 | 0.78 | N/A |
| Dividend Share (%) | 30.93 | 75.22 | 27.47 | 26.15 | N/A |
| Book NAV (HKD) | 1.859 | 1.673 | 1.716 | 1.725 | N/A |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 419.09 | 403.728 | +3.8 | 396.194 |
| Operating Result | 105.995 | 120.148 | -11.8 | 110.741 |
| Associates | -0.467 | 0 | N/A | 0 |
| Profit Before Taxation | 105.528 | 120.148 | -12.2 | 110.741 |
| Taxation | 11.029 | 8.325 | +32.5 | 9.801 |
| Profit /( Loss) After Taxation | 94.499 | 111.823 | -15.5 | 100.94 |
| Minority Interests | 1.062 | 1.174 | -9.5 | -1.092 |
| Net Profit | 93.437 | 110.649 | -15.6 | 102.032 |
| Earnings Per Share () | 0.2302 | 0.2869 | -19.8 | 0.2639 |
| Dividend Per Share () | 0.0712 | 0.2158 | -67.0 | 0.0725 |
| Announcement Date | 2026-03-27 | 2025-03-28 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
